Janssen-Cilag Ltd

50 - 100 Holmers Farm Way, High Wycombe, Bucks, HP12 4EG
Telephone: +44 (0)1494 567 567
Fax: +44 (0)1494 567 568
WWW: http://www.janssen.co.uk
WWW: http://www.janssen-medinfo.co.uk
Medical Information Direct Line: +44 (0)800 731 8450
Medical Information e-mail: medinfo@janssen-cilag.co.uk
Customer Care direct line: +44 (0)800 731 5550

Patient Information Leaflet last updated on the eMC: 28/05/2010
PIL Rapifen 500 micrograms/ml solution for injection or infusion

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 28/05/2010 and displayed until Current
Reasons for adding or updating:
  • Change to date of revision
  • Change to side-effects
  • Change to drug interactions
Updated on 20/07/2009 and displayed until 28/05/2010
Reasons for adding or updating:
  • Improved Electronic Presentation
  • Change to date of revision
Updated on 16/04/2009 and displayed until 20/07/2009
Reasons for adding or updating:
  • Change to date of revision
  • Change to storage instructions
Updated on 07/07/2008 and displayed until 16/04/2009
Reasons for adding or updating:
  • Change to MA holder contact details
Updated on 30/05/2008 and displayed until 07/07/2008
Reasons for adding or updating:
  • Change of inactive ingredient
Updated on 17/05/2007 and displayed until 30/05/2008
Reasons for adding or updating:
  • Change of inactive ingredient
Updated on 01/03/2007 and displayed until 17/05/2007
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to storage instructions
  • Change to side-effects
Updated on 18/09/2000 and displayed until 01/03/2007
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   alfentanil hydrochloride